CIPHER PHARMACEUTICALS, INC. v. WATSON LABORATORIES, INC.-FLORIDA
1:13-cv-06502
Overview
Parties
Defendant
RANBAXY PHARMACEUTICALS, INC. Operating Company
Represented By
3 Attorneys ListedRespondent
RANBAXY, INC. Operating Company
Represented By
3 Attorneys ListedCounter Claimant
ACTAVIS LABORATORIES FL, INC. Operating Company
Represented By
3 Attorneys ListedCounter Defendant
CIPHER PHARMACEUTICALS, INC. Operating Company
Represented By
3 Attorneys ListedCourt & Judges
Court
District Court, D. New Jersey (njd)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 6 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | US 8,367,102 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 2013009619 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 8,952,064 B2 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 9,089,534 B2 | US Continuation / Sibling | View Official Patent → |
| 🌐 PCT International (WIPO) | WO 2002024172 A1 | PCT World Application | View Official Patent → |
| 🇺🇸 United States | US 7,435,427 B2 | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There is a single patent involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US8367102
Pharmaceutical semi-solid composition of isotretinoin
|
Filed: 2007-08-22
Issued: 2013-02-05
|
Expired (Term Ended)
Expires: 2025-08-22
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.
Standard Statutory Term — No obviousness-type double patenting truncation noted.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
32
Dispositive
0
Granted
13
Denied
0
Pending / Review
17
Motions by Category
Key Dispositive Motions & Rulings